Manuscripts

Search by keyword, year, or author name.

Showing 1591 manuscripts.

Evaluation of high protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial

Fred Richard Sattler, M.D., Natasa Rajicic, M.S., Kathleen Mulligan, Ph.D., Kevin E. Yarasheski, Ph.D., Susan L. Koletar, M.D., Andrew R. Zolopa, M.D., Beverly L. Alston-Smith, M.D., Robert Zackin, Sc.D., Bruce Bistrian, M.D., Ph.D. Evaluation of high protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. American Journal of Clinical Nutrition. 2008 Nov 01; 88(5):1313-21. PMCID: PMC2797483.

Year

2008

Journal

American Journal of Clinical Nutrition

Lopinavir exposure with an increased dose during pregnancy

Mark Mirochnick, Brookie M Best, Alice M Stek, Edmund Capparelli, ChengCheng Hu, Sandra K Burchett, Diane T Holland, Elizabeth Smith, Sreedhar Gaddipati, Jennifer S Read, PACTG 1026s Study Team. Lopinavir exposure with an increased dose during pregnancy. Journal of Acquired Immune Deficiency Syndromes. 2008 Dec 15; 49(5):485-91. PMID: 18989231; PMCID: PMC3912695.

Year

2008

Journal

Journal of Acquired Immune Deficiency Syndromes

Study

P1026S

Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095

Bruce R. Schackman, Ph.D., Heather Ribaudo, Ph.D., Amy Krambrink, M.S., Valery Hughes, F.N.P., Daniel R. Kuritzkes, M.D., Roy (Trip) Gulick, M.D., M.P.H. Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095. Journal of Acquired Immune Deficiency Syndromes. 2007 Dec 15; 46(5):547-54. PMID: 18193496.

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes

Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients

Rahul P. Bakshi, Fayez Hamzeh, M.D., Ph.D., Ian Frank, M.D., Joseph J. Eron, Jr., M.D., Ronald J. Bosch, Ph.D., Susan L Rosenkranz, Ph.D., Yoninah S. Cramer, M.S., Michael Ussery, Ph.D., Charles Flexner, M.D. Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients. AIDS Research and Human Retroviruses. 2007 Nov 01; 23(11):1360-5. PMID: 18184078.

Year

2007

Journal

AIDS Research and Human Retroviruses

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment

Giovanni Schifitto, M.D., Jiameng Zhang, Ph.D., Scott Evans, Ph.D., Ned Sacktor, M.D., David M. Simpson, M.D., Linda L. Millar, B.S., Vivian (Lang) M. Hung, M.P.H., Eric N. Miller, Ph.D., Elizabeth (Betsy) Smith, M.D., Ronald J. Ellis, M.D.,Ph.D., Victor G. Valcour, M.D., Elyse J. Singer, M.D., Christina M. Marra, M.D., Dennis Kolson, M.D., Ph.D., James Weihe, M.D., Rory P. Remmel, Ph.D., David Katzenstein, M.D., David B. Clifford, M.D. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology. 2007 Sep 25; 69(13):1314-21. PMID: 17652642.

Year

2007

Journal

Neurology

A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain

Scott Evans, Ph.D., David M. Simpson, M.D., Doug Kitch, M.S., Agnes King, David B. Clifford, M.D., Bruce A. Cohen, M.D., Justin C. McArthur, M.B.B.S., M.P.H. A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. Public Library of Science Clinical Trials. 2007 Jul 25; 2(6):e551.

Year

2007

Journal

Public Library of Science Clinical Trials

Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of adult clinical trials group 384

Michael P. Dube, M.D., Lauren Komarow, M.S., Kathleen Mulligan, Ph.D., Steven K. Grinspoon, M.D., Robert A. Parker, Sc.D., Gregory K. Robbins, M.D., M.P.H., Ronenn Roubenoff, M.D., M.H.S., Pablo Tebas, M.D. Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of adult clinical trials group 384. Journal of Acquired Immune Deficiency Syndromes. 2007 Aug 15; 45(5):508-14.

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes

Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study

Junfeng Sun, Haikady N. Nagaraja, Ph.D., Nancy Radcliffe Reynolds, Ph.D. Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study. Biometrics. 2007 Aug 01; 49(5):731-41.

Year

2007

Journal

Biometrics

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV

Grace McComsey, M.D., Michelle A. Kendall, M.S., Pablo Tebas, M.D., Susan Swindells, M.B.B.S., Evelyn Hogg, B.A., Beverly L. Alston-Smith, M.D., Carol Suckow, B.S.N., Geetha Gopalakrishnan, M.D., Constance A. Benson, M.D., David Alain Wohl, M.D. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS. 2007 Nov 30; 21(18):2473-82.

Year

2007

Journal

AIDS